Produkty 5696-51-5

CAS 5696-51-5 występuje w naszej ofercie pod nazwami: 5b-Estrane-3,17-dione, 5Beta-Estrane-3,17-dione, (3aS,3bR,5aR,9aS,9bR,11aS)-11a-methyl-hexadecahydro-1H-cyclopenta(a)phenanthrene-1,7-dione. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 100mg, 25mg, 50mg, 250mg.

5b-Estrane-3,17-dione
TRC
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
5Beta-Estrane-3,17-dione
TRC
  • opakowanie: 25mg, 50mg
  • Warianty: 2
Zobacz produkt
(3aS,3bR,5aR,9aS,9bR,11aS)-11a-methyl-hexadecahydro-1H-cyclopenta(a)phenanthrene-1,7-dione
Biosynth
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5R,8R,9R,10S,13S,14S)-13-methyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-dione (CAS 5696-51-5) to związek chemiczny o wzorze sumarycznym C18H26O2 i masie molowej 274.4 g/mol. Nazwa systematyczna IUPAC: (5R,8R,9R,10S,13S,14S)-13-methyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-dione. InChIKey: CRDKSBHJIGNEOH-ARAASWILSA-N.

Dane identyfikacyjne
Wzór sumarycznyC18H26O2
Masa molowa274.4 g/mol
Nazwa IUPAC(5R,8R,9R,10S,13S,14S)-13-methyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-dione
InChIKeyCRDKSBHJIGNEOH-ARAASWILSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@H]4[C@@H]3CCC(=O)C4

Dane obliczone przez PubChem (NCBI)

Synonimy: (5beta)-Estrane-3,17-dione, 5b-Estrane-3,17-dione, 5beta-estrane-3,17-dione, 5 beta-Estrane-3,17-dione, (5|A)-Estrane-3,17-dione
Powiązane formy tego związku
(5S,8R,9R,10S,13S,14S)-13-methyl-1,2,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-dione C18H26O2
(5S,8R,9R,10S,13S,14S)-2,2,4,4,16,16-hexadeuterio-13-methyl-5,6,7,8,9,10,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione C18H26O2
Izomery (ten sam wzór sumaryczny)
4-methylhept-4-en-1-yn-3-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate C18H26O2
4-(4-pentylcyclohexyl)benzoic acid C18H26O2
(8R,9S,10R,13S,14S,17R)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C18H26O2
(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one C18H26O2
(8R,9S,10R,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-one C18H26O2
(3S,8R,9S,10R,13S,14S)-3-hydroxy-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one C18H26O2
(3R,8R,9S,10R,13S,14S)-3-hydroxy-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-one C18H26O2
4,6,6,7,8,8-hexamethyl-1,3,4,7-tetrahydrocyclopenta[g]isochromen-1-ol C18H26O2
(3S,5S,8R,9S,10R,13S,14S)-3-hydroxy-13-methyl-4,5,6,7,8,9,10,11,12,14,15,16-dodecahydro-3H-cyclopenta[a]phenanthren-17-one C18H26O2
(1S,2R,4R)-1-methyl-2-[(2-methylphenyl)methoxy]-4-propan-2-yl-7-oxabicyclo[2.2.1]heptane C18H26O2